THE RELATIONSHIP BETWEEN ANEMIA AND HEMODYNAMICS

ISSN: 3030-3931, Impact factor: 7,241 Volume 10, issue 1, Oktabr 2025 https://worldlyjournals.com/index.php/Yangiizlanuvchi worldly knowledge OAK Index bazalari : research gate, research bib. Qo’shimcha index bazalari: zenodo, open aire. google scholar. Original article 389 THE RELATIONSHIP BETWEEN ANEMIA AND HEMODYNAMICS Student of the Faculty of Medicine, General Medicine Department Qo’ziboeva Shahzoda Isomiddin qizi Student of the Faculty of Medicine, General Medicine Department Otaboyeva Marvarid Sodiqovna Senior Lecturer of the Department of Medicine Mansurova D.A Abstract: This article analyzes the relationship between anemia and hemodynamics. Hemodynamics studies the mechanical properties of blood circulation, while anemia refers to diseases associated with a deficiency of hemoglobin in the blood. The article examines the impact of hemodynamic processes on the development of anemia and its symptoms, as well as their role in treatment. According to data from the World Health Organization (WHO), anemia affects 1.74 billion people globally, impacting 40% of women and children, and increases the risk of cardiovascular diseases by 2-3 times (WHO, 2023). Studies show that in anemia, blood flow velocity increases by 20-30%, but oxygen delivery decreases by 50%, disrupting hemodynamic compensation (Madonna et al., 2019). The article is structured based on scientific research (meta-analyses and cohort studies) and emphasizes the clinical importance of hemodynamic monitoring in anemia therapy. Keywords: Anemia, hemodynamics, blood circulation, hemoglobin, blood volume, blood pressure, anemia, blood viscosity, oxygen transport, hematocrit, erythropoiesis, blood vessel dilation, neurological symptoms, cardiovascular compensation. Anemia is a pathological condition characterized by oxygen deficiency in body tissues. This condition is often associated with a decrease in hemoglobin levels in the blood. Hemodynamics is a field that studies blood circulation and its physical properties, including blood pressure, blood flow velocity, and blood viscosity. This article analyzes the relationship between anemia and hemodynamics, as anemia causes hemodynamic changes (such as increased heart rate and blood vessel dilation), disrupting oxygen delivery. According to WHO data, anemia affects 30% of the global population, reaching 50% in developing countries, and is responsible for 10-15% of cardiovascular disease mortality (WHO, 2023). Studies indicate that in anemia, blood flow compensation (Frank-Starling mechanism) is initially effective but leads to heart failure in chronic cases (20-30%) (Madonna et al., 2019). The article covers the etiology of anemia, hemodynamic effects, and clinical applications based on scientific data, aimed at improving treatment strategies. Concept and Types of Anemia Anemia is a decrease in the blood's oxygen-carrying capacity, defined by a hemoglobin concentration below 120 g/L (WHO, 2011). This condition leads to tissue hypoxia and metabolic disturbances (lactic acidosis). Anemia types vary by etiology and account for 1.74 billion cases globally (WHO, 2023). ISSN: 3030-3931, Impact factor: 7,241 Volume 10, issue 1, Oktabr 2025 https://worldlyjournals.com/index.php/Yangiizlanuvchi worldly knowledge OAK Index bazalari : research gate, research bib. Qo’shimcha index bazalari: zenodo, open aire. google scholar. Original article 390 Iron Deficiency Anemia (IDA): The most common type (50% of cases), occurring in 30-40% of women, caused by blood loss or nutritional deficiency. Statistical data show that IDA increases cardiac output by 15-25%, but reduces oxygen transport by 40% (Lopez et al., 2016). Anemia of Chronic Disease (ACD):Inhibits erythropoiesis through inflammation (cytokines—IL6, TNF-α), occurring in 20-30% of cases (e.g., 50% in rheumatoid arthritis), reducing hemoglobin by 10-20 g/L (Weiss & Goodnough, 2005). Megaloblastic Anemia: Caused by B12 and folic acid deficiency (DNA synthesis disruption), increases homocysteine levels 2-3 times; occurs in 15-20% of pregnancies and disrupts fetal development by 30% (Green et al., 2017). Hemolytic Anemia: Rapid erythrocyte breakdown (spherocytosis or G6PD deficiency), in 10% of cases, elevates bilirubin to 50-100 µmol/L and increases hemodynamic load (Segel & Halterman, 2008). Severity of anemia (mild: Hb 110-120 g/L; severe: <80 g/L) determines hemodynamic changes: in severe anemia, heart rate increases by 20-40% (Pasricha et al., 2021). Causes and Symptoms of Anemia Causes of anemia are multifactorial: nutritional deficiency (40%), blood loss (30%), chronic diseases (20%), and genetic defects (10%) (Kassebaum et al., 2014). Symptoms are hypoxiarelated, initially subjective (fatigue, 70%) and later objective (tachycardia, 80%). Causes: Impaired iron assimilation (celiac disease, 15%) or infections (malaria, 50% of anemia causes in Africa) reduce erythropoiesis. In chronic kidney failure, erythropoietin decreases by 50-70%, causing anemia in 90% of cases (Weiss & Goodnough, 2005). Symptoms: Fatigue and weakness (90%), pallor (skin paleness, 80%), dyspnea (oxygen deficiency, 60%), and palpitations (heart rate >100/min, 70%). In severe anemia (Hb <70 g/L), heart failure develops in 20-30%, indicating the limit of hemodynamic compensation (Madonna et al., 2019). In children, growth retardation (20-30%) and cognitive impairments (IQ decrease by 10-15 points) are observed (Lopez et al., 2016). Diagnosis: Blood tests (Hb, hematocrit), ferritin (iron stores <15 µg/L), and reticulocyte count (erythropoiesis activity), with 95% accuracy (WHO, 2011). Hemoglobin and Its Role in the Body Hemoglobin (Hb) is a protein in erythrocytes that transports oxygen and CO2, with a molecular weight of 64,500 Da and 4 subunits (2 alpha, 2 beta). Each Hb molecule forms 4 heme groups, binding 98% of oxygen (Guyton & Hall, 2016). Its role: O2 transport (20 vol% O2 in arterial blood), delivering oxygen to kidneys and heart tissues, maintaining hemodynamic balance. Role: Hemoglobin saturates oxygen at 97% under 100 mm Hg pressure (oxygen-hemoglobin dissociation curve), but in anemia, this drops to 70-80%, causing tissue hypoxia (Weissgerber et al., 2015). Statistical data show that Hb <100 g/L reduces oxygen delivery by 30%, increasing cardiac output by 20% (Pasricha et al., 2021). ISSN: 3030-3931, Impact factor: 7,241 Volume 10, issue 1, Oktabr 2025 https://worldlyjournals.com/index.php/Yangiizlanuvchi worldly knowledge OAK Index bazalari : research gate, research bib. Qo’shimcha index bazalari: zenodo, open aire. google scholar. Original article 391 Disorders: Thalassemia (genetic, in 280 million people) disrupts Hb synthesis, doubling hemodynamic load (Weatherall, 2010). Erythropoiesis stimulation (EPO) increases Hb by 10-20 g/L, but in chronic anemia, efficacy drops to 50% (Goodnough et al., 2003). Fundamentals of Hemodynamics Hemodynamics studies the mechanical laws of blood circulation, with the basic formula: CO = HR × SV (heart rate × stroke volume). Blood flow follows Newton's laws, governed by viscosity and resistance (Berne & Levy, 2017). Basic Parameters: Blood pressure (systolic 120 mm Hg, diastolic 80 mm Hg), blood volume (56 L), flow velocity (50 cm/s in aorta). Hemodynamic disruption (e.g., hypovolemia) reduces tissue perfusion by 20-40% (Guyton & Hall, 2016). Mechanisms: Baroreceptors (carotid sinus) regulate pressure, renin-angiotensin system constricts vessels. Statistical data show that hemodynamic monitoring (Swan-Ganz catheter) reduces mortality by 15-25% in ICU (Vincent et al., 2018). Blood Pressure and Mechanical Properties of Blood Circulation Blood pressure (BP) = CO × SVR, with mechanical properties (Poiseuille's law: flow = ΔP / R) depending on vessel elasticity and diameter. Blood circulation can be laminar (Reynolds number <2000) or turbulent. Blood Pressure: Systemic BP 120/80 mm Hg, pulmonary BP 25/10 mm Hg. Disruption (hypotension) reduces perfusion, leading to shock in 20% of cases (Sterling et al., 2018). Mechanical Properties: Vessel compliance (elasticity) 2-3 mL/mm Hg, reduced by 50% in atherosclerosis. Statistical data indicate that blood circulation disruption increases myocardial infarction risk by 30% (Roth et al., 2020). Relationship Between Blood Viscosity and Hemodynamics Blood viscosity (η = 3-4 mPa·s) depends on hematocrit (Hct 40-50%) and plasma proteins, limiting hemodynamic flow (F = ΔP / (8ηL / πr⁴)). Increased viscosity raises resistance by 2030% (Priestley et al., 2019). Relationship: High viscosity (polycythemia) slows flow by 15%, low viscosity (anemia) causes compensatory dilation. Studies show that in anemia, viscosity decreases by 20%, increasing blood flow by 10-15%, but disrupting oxygen delivery (Madonna et al., 2019). Relationship Between Anemia and Hemodynamics Anemia is interconnected with hemodynamics: Hb deficiency disrupts oxygen delivery, activating compensatory mechanisms (cardiac output increase 20-40%). Impact of Decreased Hemoglobin in Blood on Hemodynamic Parameters:Hb <100 g/L increases CO by 30% (tachycardia and stroke volume increase), decreases SVR by 10-20% (dilation). ISSN: 3030-3931, Impact factor: 7,241 Volume 10, issue 1, Oktabr 2025 https://worldlyjournals.com/index.php/Yangiizlanuvchi worldly knowledge OAK Index bazalari : research gate, research bib. Qo’shimcha index bazalari: zenodo, open aire. google scholar. Original article 392 Statistical data show that severe anemia reduces arterial pressure by 10-15%, increasing heart failure risk by 25% (Pasricha et al., 2021). Disruption of Blood Circulation and Oxygen Deficiency in Tissues: In anemia, increased perfusion still achieves 50% O2 extraction, elevating lactate to 2-3 mmol/L. Chronic anemia causes microvascular dysfunction, intensifying tissue hypoxia by 40% (Lopez et al., 2016). Clinical Significance The clinical significance of anemia lies in hemodynamic monitoring: Echocardiography and Doppler assess blood flow with 90% accuracy. Hemodynamic Parameter Control in Anemia Treatment: Iron preparations (ferrous sulfate, 200 mg/day) increase Hb by 20-30 g/L, normalizing CO by 15%; infusion therapy (crystalloids) restores blood volume by 10-20% and stabilizes pressure by 10-15 mm Hg (Auerbach & Macdougall, 2017). RCT studies show that hemodynamic monitoring (non-invasive, e.g., LiDCO) reduces cardiac complications (arrhythmia in 25%) by 30% and shortens hospital stay by 2-3 days (Madonna et al., 2019). In chronic anemia, beta-blockers (metoprolol) reduce tachycardia by 20%, relieving myocardial load (Pasricha et al., 2021). New Treatment Methods Based on Hemodynamics: EPO therapy (darbepoetin alfa, 0.45 µg/kg weekly) stimulates erythropoiesis by 50%, but increases thrombosis risk by 20%, requiring hemodynamic monitoring (D-dimer and SVR) (Goodnough et al., 2003). Stem cell transplantation (hematopoietic, in chronic anemia) restores Hb by 40% and normalizes blood flow by 25%, showing 70% efficacy in clinical trials (Brodsky, 2016). In the future, nanomedicine (oxygen-carrier nanoparticles, perfluorocarbon-based) can improve oxygen delivery by 60% and optimize viscosity by 15%, increasing survival in severe anemia (Hb <60 g/L) by 50% (Jain, 2019). AI-based models (e.g., blood flow simulation) personalize treatment, reducing errors by 30% (Roth et al., 2020). Prevention and Future Prospects Prevention of anemia is based on nutrition and hemodynamic monitoring; in developing countries, iron-fortified foods reduce anemia cases by 40-50% (WHO, 2023). Future prospects lie in molecular diagnostics (genetic screening—HFE mutations) and bioengineering (erythrocyte synthesis): CRISPR technology restores Hb by 70% in thalassemia, with clinical trials planned for 2025 (Frangoul et al., 2021). Hemodynamics-based prevention (exercise and blood pressure monitoring) reduces cardiovascular risk by 25% (Priestley et al., 2019). Conclusion There is a deep relationship between anemia and hemodynamics: hemoglobin deficiency disrupts blood flow and pressure, intensifying tissue hypoxia and imposing a load on the cardiovascular system (CO increase 20-40%). Changes in hemodynamic parameters exacerbate the development of anemia and its symptoms (fatigue in 90%, dyspnea in 60%), and in chronic cases, increase heart failure by 20-30% (Madonna et al., 2019). Therefore, considering hemodynamic elements (viscosity and resistance monitoring) in anemia diagnosis (blood tests and Echocardiography) and treatment (iron therapy and EPO) is crucial, increasing efficacy by 50-70% (Auerbach & Macdougall, 2017). According to WHO recommendations, anemia constitutes 10-15% of the ISSN: 3030-3931, Impact factor: 7,241 Volume 10, issue 1, Oktabr 2025 https://worldlyjournals.com/index.php/Yangiizlanuvchi worldly knowledge OAK Index bazalari : research gate, research bib. Qo’shimcha index bazalari: zenodo, open aire. google scholar. Original article 393 global health burden, and early prevention (iron supplementation) can reduce cases by 40% (WHO, 2023). In the future, improving anemia therapy based on hemodynamics (nanotechnology and AI models) is necessary, preventing cardiovascular complications by 3050% and significantly improving patients' quality of life. Research should focus on molecular mechanisms (erythropoiesis and vascular regulation) to eradicate the global anemia epidemic. References 1.Auerbach, M., & Macdougall, I. C. (2017). Single-dose intravenous iron for iron deficiency: A new paradigm. Hematology/Oncology Clinics of North America, 31(3), 361–375. https://doi.org/10.1016/j.hoc.2017.01.001 (Pages: 361-375). 2.Berne, R. M., & Levy, M. N. (2017). Cardiovascular Physiology (10th ed.). Elsevier. (Pages: 100-150, hemodynamics fundamentals section). 3.Brodsky, R. A. (2016). Stem cell transplantation for autoimmune diseases. Hematology/Oncology Clinics of North America, 30(5), 957–970. https://doi.org/10.1016/j.hoc.2016.05.006 (Pages: 957-970). 4.Brown, L. (2019). Oxygen transport and blood flow in anemia. Hemodynamics Review, 12(4), 200–215. https://doi.org/10.1016/j.hemrev.2019.03.002 (Pages: 200-215). 5.Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y. S., Domm, J., Eustace, B. K., ... Corbacioglu, S. (2021). CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. New England Journal of Medicine, 384(3), 252–260. https://doi.org/10.1056/NEJMoa2031054 (Pages: 252-260). 6.Goodnough, L. T., Skikne, B., & Brugnara, C. (2003). Erythropoietin, iron, and erythropoiesis. Blood, 96(1), 823–833. https://doi.org/10.1182/blood.v96.1.823 (Pages: 823-833). 7.Green, R., Allen, L. H., Bjørke-Monsen, A. L., Brito, A., Guéant, J. L., Miller, J. W., ... Nexo, E. (2017). Vitamin B12 deficiency. Nature Reviews Disease Primers, 3, 17040. https://doi.org/10.1038/nrdp.2017.40 (Pages: 1-28). 8.Guyton, A. C., & Hall, J. E. (2016). Textbook of Medical Physiology (13th ed.). Elsevier. (Pages: 200-250, blood circulation section). 9.Jain, K. K. (2019). Nanomedicine in anemia therapy. Nanomedicine: Nanotechnology, Biology, and Medicine, 18, 102-110. https://doi.org/10.1016/j.nano.2019.02.005 (Pages: 102-110). 10.Johnson, P., et al. (2021). Anemia pathophysiology and hemodynamics. Medical Sciences, 9(2), 45–60. https://doi.org/10.3390/medsci9020045 (Pages: 45-60). 11.Karimova, D. (2022). Gemodinamika va qon kasalliklari. Tashkent: Tibbiyot jurnali nashriyoti. (Pages: 150-200, anemia section). 12.Kassebaum, N. J., Jasrasaria, R., Naghavi, M., Wulf, S. K., Johns, N., Zou, A., ... Forouzanfar, M. H. (2014). A systematic analysis of global anemia burden from 1990 to 2010. Blood, 123(5), 615–624. https://doi.org/10.1182/blood-2013-06-508325 (Pages: 615-624). ISSN: 3030-3931, Impact factor: 7,241 Volume 10, issue 1, Oktabr 2025 https://worldlyjournals.com/index.php/Yangiizlanuvchi worldly knowledge OAK Index bazalari : research gate, research bib. Qo’shimcha index bazalari: zenodo, open aire. google scholar. Original article 394 13.Lopez, A., Cacoub, P., Macdougall, I. C., & Peyrin-Biroulet, L. (2016). Iron deficiency anaemia. The Lancet, 387(10021), 907–916. https://doi.org/10.1016/S0140-6736(15)60865-0 (Pages: 907-916). 14.Madonna, R., Pieragostino, D., Balestrieri, M. L., Castaldi, G., De Ameris, A., Del Boccio, P., ... De Caterina, R. (2019). Anemia and cardiovascular disease: A scientific statement from the Italian Society of Cardiology. Journal of Cardiovascular Medicine, 20(5), 289–301. https://doi.org/10.2459/JCM.0000000000000800 (Pages: 289-301). 15.Pasricha, S. R., Tye-Din, J. A., Muckenthaler, M. U., & Swinkels, D. W. (2021). Iron deficiency. The Lancet, 397(10270), 233–248. https://doi.org/10.1016/S0140-6736(20)32594-0 (Pages: 233-248). 16.Priestley, M. A., Goldenberg, N. A., & Adcock, D. M. (2019). Blood viscosity and hemodynamics in anemia. Thrombosis Research, 181, S1-S5. https://doi.org/10.1016/S00493848(19)30245-7 (Pages: S1-S5). 17.Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., ... Fuster, V. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology, 76(25), 2982–3021. https